MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202647123663 A) filed by Eisai R&d Management Co. , Ltd. on October 15, 2026, for Anti-Trop2 Antibody-Drug Conjugates And Methods Of Use.
Inventors include Spidel, Jared; Albone, Earl F.; Cheng, Xin; Furuuchi, Keiji; and Kira, Kazunobu.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Antibodies, antigen-binding fragments, and conjugates (e.g., antibody-drug conjugates) thereof that bind TROP2 are disclosed, as well as improved linkers for antibody-drug conjugates. The disclosure further relates to methods and compositions for use in the treatment of, e.g., cancer by administering the compositions ...